The Potential of AI in Your Hands.

EVIDENS, our AI platform enables digital cohort discovery, research, collaboration, and insight sharing on hospital-wide data sets.

Unlock the Full Potential of Your Data

  • Quickly annotate and link your data into AI-ready data sets
  • Quickly filter populations based on clinical outcomes or demographics
  • Filter populations with limitless keywords by training AI models to search with them
Request Info

Leverage AI to Derive Clinical Insights

  • Explore and create criteria to identify cohorts with smart AI assistance
  • Quickly train AI models to automate analysis and categorize data into groups
  • Output AI-ready cohorts to test your study’s clinical hypothesis
Request Info

Enable Collaboration & Federated Learning

  • Easily view the status and tasks for all your projects and collaborators
  • View and follow activity based on your research interests and projects
  • Use collaborative tools to work in parallel to create, train and validate AI models
Request Info

Our Platform Partners

The latest on EVIDENS

Digital Technology Supercluster Announces Investment to Increase the Effectiveness of Precision Oncology

Digital Technology Supercluster Announces Investment to Increase the Effectiveness of Precision Oncology

Harnessing artificial intelligence to take the guesswork out of diagnosing cancer recurrence for millions of cancer survivors

Read more
How to Bring Biomarker Testing In-House for Cancer Targeted Treatment Selection

How to Bring Biomarker Testing In-House for Cancer Targeted Treatment Selection

Personalized cancer treatment via targeted therapies is two-to-three times more effective than standard chemotherapy for patients with advan

...
Read more
Imagia Cybernetics & Canexia Health Merge to Supercharge Precision Oncology Accessibility

Imagia Cybernetics & Canexia Health Merge to Supercharge Precision Oncology Accessibility

Imagia Cybernetics, an AI-healthcare company that accelerates oncology solutions generated from real world data, today announced its merger

...
Read more

Interested in a demo of the EVIDENS platform?

Contact us